Pricing
Prices are indicative MRP and may vary by pharmacy. Trend compares against the last recorded price.
All price changes →Save on this medicine
Same active ingredient — pay up to 45% less
These brands contain the same active ingredient (Palonosetron). Strength and form may differ — confirm substitution with your doctor or pharmacist before switching.
Indications & Uses
Paloxi ODT is indicated for:
Dosage Reference
Reference Information Only
Dosages shown are general references from official sources. Always consult your doctor or pharmacist for personalized dosing.
Adults:
Usual dosage: for adults, the tablet dose is 0.5 mg daily, and the intravenous dose is a single 0.075 mg injection given over 10 seconds. For chemotherapy-induced nausea and vomiting, adults take a 0.5 mg tablet about 1 hour before chemotherapy begins, or receive a single 0.25 mg intravenous dose given over 30 seconds about 30 minutes before chemotherapy begins. For radiotherapy-induced nausea and vomiting, a single 0.25 mg intravenous dose is given over 30 seconds about 30 minutes before each week of radiation fraction. For post-operative nausea and vomiting, a single 0.075 mg intravenous dose is given over 10 seconds immediately before anaesthesia is induced. For children aged 1 month to 17 years, a single intravenous dose of 20 mcg per kg of body weight is given, up to a maximum of 1.5 mg.
Side Effects
The most commonly reported side effects of palonosetron are headache and constipation.
Cautions & Contraindications
Contraindications
Palonosetron should not be used in anyone with a known hypersensitivity (allergy) to palonosetron or to any of the other ingredients in the product.